MONOD® is an exclusive, NGS-based methylation feature marker screening method licensed to Singlera Genomics. It pioneered a non-invasive plasma-based method for tumor detection and tracing, utilizing a highly sensitive methylation haplotype analysis approach.

• Two day workflow (from DNA to next-generation sequencer)

• Broad-scale sequencing identifies methylation haplotypes genome-wise

• Interrogates millions of CpG sites across tens of thousands of genomic regions

• Retains methylation haplotype information lost by traditional methylation analysis approaches

• Requires only a single 10 mL tube of blood!